The dynamics of HER2-low expression during breast cancer progression
Sarah Anderson, Brooke B. Bartow, Gene P. Siegal, Xiao Huang, Shi Wei
Topics & Concepts
TrastuzumabBreast cancerMedicineInternal medicineOncologyAntibodyCancerHER2/neuAntibody-drug conjugateCancer researchImmunologyMonoclonal antibodyHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies